Erratum: Parameters related to a positive test result for FDG PET(/CT) for large vessel vasculitis: A multicenter retrospective study (Clin Rheumatol doi 10.1007/s10067-012-1945-0);Parameters related to a positive test result for FDG PET(/CT) for large vessel vasculitis: A multicenter retrospective study

Clinical Rheumatology

Volumn 31, Issue 5, 2012, Pages 861-871

  Hooisma, G A ^a   Balink, H ^a   Houtman, P M ^a   Slart, R H J A ^c   Lensen, K D F ^b  

^a MEDICAL CENTER LEEUWARDEN   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Artralgia; CT; Erythrocyte sedimentation rate; Large vessel vasculitis

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTHRALGIA; ARTICLE; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC VALUE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; LARGE VESSEL VASCULITIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX DIFFERENCE; TEMPORAL ARTERITIS; THROMBOCYTE COUNT; VASCULITIS;

EID: 84863724759     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-012-1974-8     Document Type: Erratum

References (58)

1. Jennette JC, Falk RJ, Andrassy K et al (1994) Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37:187-192
2. Gornik HL, CreagerMA (2008) Aortitis. Circulation 117:3039-3051
3. Levine SM, Hellmann DB (2002) Giant cell arteritis. Curr Opin Rheumatol 14:3-10
4. Walter MA (2007) [(18)F]fluorodeoxyglucose PET in large vessel vasculitis. Radiol Clin North Am 45:735-744, viii
5. Salvarani C, Cantini F, Hunder GG (2008) Polymyalgia rheumatica and giant-cell arteritis. Lancet 372:234-245
6. Bongartz T, Matteson EL (2006) Large-vessel involvement in giant cell arteritis. Curr Opin Rheumatol 18:10-17
7. Janssen SP, Comans EH, Voskuyl AE, Wisselink W, Smulders YM (2008) Giant cell arteritis: heterogeneity in clinical presentation and imaging results. J Vasc Surg 48:1025-1031
8. Cantini F, Niccoli L, Storri L et al (2004) Are polymyalgia rheumatica and giant cell arteritis the same disease? Semin Arthritis Rheum 33:294-301
9. Blockmans D, Stroobants S, Maes A, Mortelmans L (2000) Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch. Am J Med 108:246-249
10. Gonzalez-Gay MA, Garcia-Porrua C, Llorca J, Gonzalez-Louzao C, Rodriguez-Ledo P (2001) Biopsy-negative giant cell arteritis: clinical spectrum and predictive factors for positive temporal artery biopsy. Semin Arthritis Rheum 30:249-256
11. Mari B, Monteagudo M, Bustamante E et al (2009) Analysis of temporal artery biopsies in an 18-year period at a community hospital. Eur J Intern Med 20:533-536
12. Taylor-Gjevre R, Vo M, Shukla D, Resch L (2005) Temporal artery biopsy for giant cell arteritis. J Rheumatol 32:1279-1282
13. Chong EW, Robertson AJ (2005) Is temporal artery biopsy a worthwhile procedure? ANZ J Surg 75:388-391
14. Hayreh SS, Podhajsky PA, Raman R, Zimmerman B (1997) Giant cell arteritis: validity and reliability of various diagnostic criteria. Am J Ophthalmol 123:285-296
15. Maksimowicz-McKinnon K, Clark TM, Hoffman GS (2009) Takayasu arteritis and giant cell arteritis: a spectrum within the same disease? Medicine (Baltimore) 88:221-226
16. Park MC, Lee SW, Park YB, Chung NS, Lee SK (2005) Clinical characteristics and outcomes of Takayasu's arteritis: analysis of 108 patients using standardized criteria for diagnosis, activity assessment, and angiographic classification. Scand J Rheumatol 34:284-292
17. Mwipatayi BP, Jeffery PC, Beningfield SJ et al (2005) Takayasu arteritis: clinical features and management: report of 272 cases. ANZ J Surg 75:110-117
18. Kissin EY, Merkel PA (2004) Diagnostic imaging in Takayasu arteritis. Curr Opin Rheumatol 16:31-37
19. Ahmadi-Simab K, Hellmich B, Holl-Ulrich K, Fleischmann C, Dourvos O, Gross WL (2007) Acute coronary syndrome in Takayasu arteritis without elevation of acute phase parameters. Rheumatology (Oxford) 46:554-555
20. Hoffman GS, Ahmed AE (1998) Surrogate markers of disease activity in patients with Takayasu arteritis. A preliminary report from The International Network for the Study of the Systemic Vasculitides (INSSYS). Int J Cardiol 66(Suppl 1):S191-S194
21. Andrews J, Mason JC (2007) Takayasu's arteritis - recent advances in imaging offer promise. Rheumatology (Oxford) 46:6-15
22. Bartels AL, Zeebregts CJ, Bijl M, Tio RA, Slart RH (2009) Fused FDG-PET and MRI imaging of Takayasu arteritis in vertebral arteries. Ann Nucl Med 23:753-756
23. Meave A, Soto ME, Reyes PA et al (2007) Pre-pulseless Takayasu's arteritis evaluated with 18F-FDG positron emission tomography and gadolinium-enhanced magnetic resonance angiography. Tex Heart Inst J 34:466-469
24. Kaku B, Higuchi T, Kanaya H et al (2006) Usefulness of fluorine- 18-fluorodeoxyglucose positron emission tomography in a patient with Takayasu's arteritis associated with antiphospholipid syndrome. Int Heart J 47:311-317
25. Weaver FA, Kumar SR, Yellin AE et al (2004) Renal revascularization in Takayasu arteritis-induced renal artery stenosis. J Vasc Surg 39:749-757
26. Henes JC, Muller M, Krieger J et al (2008) [18F] FDG-PET/CT as a new and sensitive imaging method for the diagnosis of large vessel vasculitis. Clin Exp Rheumatol 26:S47-S52
27. Meller J, Strutz F, Siefker U et al (2003) Early diagnosis and follow-up of aortitis with [(18)F]FDG PET and MRI. Eur J Nucl Med Mol Imaging 30:730-736
28. Meller J, Grabbe E, BeckerW, Vosshenrich R (2003) Value of F-18 FDG hybrid camera PET and MRI in early Takayasu aortitis. Eur Radiol 13:400-405
29. Blockmans D, Bley T, Schmidt W (2009) Imaging for large-vessel vasculitis. Curr Opin Rheumatol 21:19-28
30. Pipitone N, Versari A, Salvarani C (2008) Role of imaging studies in the diagnosis and follow-up of large-vessel vasculitis: an update. Rheumatology (Oxford) 47:403-408
31. Zerizer I, Tan K, Khan S et al (2010) Role of FDG-PET and PET/CT in the diagnosis and management of vasculitis. Eur J Radiol 73:504-509
32. Kobayashi Y, Ishii K, Oda K et al (2005) Aortic wall inflammation due to Takayasu arteritis imaged with 18F-FDG PET coregistered with enhanced CT. J Nucl Med 46:917-922
33. Ell PJ (2006) The contribution of PET/CT to improved patient management. Br J Radiol 79:32-36
34. Hautzel H, Sander O, Heinzel A, Schneider M, Muller HW (2008) Assessment of large-vessel involvement in giant cell arteritis with 18F-FDG PET: introducing an ROC-analysis-based cutoff ratio. J Nucl Med 49:1107-1113
35. Dunphy MP, Freiman A, Larson SM, Strauss HW (2005) Association of vascular 18F-FDG uptake with vascular calcification. J Nucl Med 46:1278-1284
36. Besson FL, Parienti JJ, Bienvenu B et al (2011) Diagnostic performance of (18)F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging 38:1764-1772
37. Balink H, Bruyn GA (2007) The role of PET/CT in Cogan's syndrome. Clin Rheumatol 26:2177-2179
38. Dasgupta B (2010) Concise guidance: diagnosis and management of giant cell arteritis. Clin Med 10:381-386
39. Ezeonyeji AN, Borg FA, Dasgupta B (2011) Delays in recognition and management of giant cell arteritis: results from a retrospective audit. Clin Rheumatol 30:259-262
40. Mukhtyar C, Guillevin L, Cid MC et al (2009) EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis 68:318-323
41. Schmidt WA, Seifert A, Gromnica-Ihle E, Krause A, Natusch A (2008) Ultrasound of proximal upper extremity arteries to increase the diagnostic yield in large-vessel giant cell arteritis. Rheumatology (Oxford) 47:96-101
42. Moosig F, Czech N, Mehl C et al (2004) Correlation between 18- fluorodeoxyglucose accumulation in large vessels and serological markers of inflammation in polymyalgia rheumatica: a quantitative PET study. Ann Rheum Dis 63:870-873
43. Arnaud L, Haroche J, Malek Z et al (2009) Is (18)F-fluorodeoxyglucose positron emission tomography scanning a reliable way to assess disease activity in Takayasu arteritis? Arthritis Rheum 60:1193-1200
44. Weyand CM, Tetzlaff N, Bjornsson J, Brack A, Younge B, Goronzy JJ (1997) Disease patterns and tissue cytokine profiles in giant cell arteritis. Arthritis Rheum 40:19-26
45. Weyand CM, Hicok KC, Hunder GG, Goronzy JJ (1994) Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis. Ann Intern Med 121:484-491
46. Blockmans D, De CL, Vanderschueren S, Knockaert D, Mortelmans L, Bobbaers H (2007) Repetitive 18-fluorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatica: a prospective study in 35 patients. Rheumatology (Oxford) 46:672-677
47. Blockmans D, Maes A, Stroobants S et al (1999) New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography. Rheumatology (Oxford) 38:444-447
48. Hamrin B, Jonsson N, Hellsten S (1968) "Polymyalgia arteritica". Further clinical and histopathological studies with a report of six autopsy cases. Ann Rheum Dis 27:397-405
49. Nuenninghoff DM, Hunder GG, Christianson TJ, McClelland RL, Matteson EL (2003) Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum 48:3522-3531
50. Taniguchi Y, Arii K, Kumon Y et al (2010) Positron emission tomography/computed tomography: a clinical tool for evaluation of enthesitis in patients with spondyloarthritides. Rheumatology (Oxford) 49:348-354
51. Toriihara A, Seto Y, Yoshida K et al (2009) F-18 FDG PET/CT of polymyalgia rheumatica. Clin Nucl Med 34:305-306
52. Blockmans D, Coudyzer W, Vanderschueren S et al (2008) Relationship between fluorodeoxyglucose uptake in the large vessels and late aortic diameter in giant cell arteritis. Rheumatology (Oxford) 47:1179-1184
53. Vanderschueren S, Del BE, Ruttens D, Van B, I, Wauters E, Knockaert DD (2009) Inflammation of unknown origin versus fever of unknown origin: two of a kind. Eur J Intern Med 20: 415-8
54. Bleeker-Rovers CP, Vos FJ, Mudde AH et al (2007) A prospective multi-centre study of the value of FDG-PET as part of a structured diagnostic protocol in patients with fever of unknown origin. Eur J Nucl Med Mol Imaging 34:694-703
55. Blockmans D, Knockaert D, Maes A et al (2001) Clinical value of [(18)F]fluoro-deoxyglucose positron emission tomography for patients with fever of unknown origin. Clin Infect Dis 32:191-196
56. Buysschaert I, Vanderschueren S, Blockmans D, Mortelmans L, Knockaert D (2004) Contribution of (18)fluoro-deoxyglucose positron emission tomography to the work-up of patients with fever of unknown origin. Eur J Intern Med 15:151-156
57. Balink H, Collins J, Bruyn G, Gemmel F (2009) F-18 FDG PET/CT in the diagnosis of fever of unknown origin. Clin Nucl Med 34:862-868
58. Meller J, Sahlmann CO, Gurocak O, Liersch T, Meller B (2009) FDG-PET in patients with fever of unknown origin: the importance of diagnosing large vessel vasculitis. Q J Nucl Med Mol Imaging 53:51-63